Zobrazeno 1 - 10
of 43
pro vyhledávání: ''
Autor:
José António Lopes, Carolina Carreiro, João Oliveira, João Bernardo, Filipe Marques, Joana Gameiro, Sandra Braz, José Agapito Fonseca, Cláudia Costa
Publikováno v:
Nefrología, Vol 41, Iss 6, Pp 689-698 (2021)
Introduction: The incidence of acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients ranges from 0.5% to 35% and has been associated with worse prognosis. The purpose of this study was to evaluate the incidence, severity, duration
Autor:
Yuliya Lytvyn, Vikas S. Sridhar, David Z.I. Cherney, Patrick R. Lawler, Kevin D. Burns, Davor Brinc, Hongyan Liu, Dylan Burger, Leif E. Lovblom
Publikováno v:
Kidney International Reports
Introduction Sodium-glucose cotransporter-2 (SGLT2) inhibitors improve cardiovascular and kidney outcomes through mechanisms that are incompletely understood. In this exploratory post-hoc analysis of the VERTIS RENAL trial, we report the association
Publikováno v:
Nefrología, Vol 41, Iss 2, Pp 165-173 (2021)
Nefrología (English Edition), Vol 41, Iss 2, Pp 165-173 (2021)
Nefrología (English Edition), Vol 41, Iss 2, Pp 165-173 (2021)
Introduction and objectives: Chronic kidney disease (CKD) is a risk factor for the development of acute kidney injury (AKI). Recent studies have revealed numerous biomarkers eligible for AKI prediction. However, the expression and performance of AKI
Autor:
Sarah Yates, Andrew N. Chapman, Bruce M. Hendry, Mark Edward Carl Dockrell, Paul Roderick, Robert G. Price, Mysore K. Phanish
Publikováno v:
Kidney International Reports
Introduction Albuminuric and nonalbuminuric pathways contribute to diabetic kidney disease. Proximal tubule and inflammation play important roles in these processes. Urinary biomarker(s) to detect early kidney damage and predict progression are neede
Autor:
Bent Kristensen, Niklas Rye Jørgensen, Ditte Hansen, Rizwan Butt, Iain Bressendorff, Martin Thorbjørn Lundin
Publikováno v:
Kidney International Reports
Lundin, M T, Bressendorff, I, Kristensen, B, Jørgensen, N R, Butt, R & Hansen, D 2021, ' Randomized Trial of Acute Changes in Plasma Phosphate After Phosphorus-Standardized Meals in Peritoneal Dialysis ', Kidney International Reports, vol. 6, no. 2, pp. 304-312 . https://doi.org/10.1016/j.ekir.2020.11.003
Kidney International Reports, Vol 6, Iss 2, Pp 304-312 (2021)
Lundin, M T, Bressendorff, I, Kristensen, B, Jørgensen, N R, Butt, R & Hansen, D 2021, ' Randomized Trial of Acute Changes in Plasma Phosphate After Phosphorus-Standardized Meals in Peritoneal Dialysis ', Kidney International Reports, vol. 6, no. 2, pp. 304-312 . https://doi.org/10.1016/j.ekir.2020.11.003
Kidney International Reports, Vol 6, Iss 2, Pp 304-312 (2021)
Introduction Hyperphosphatemia is associated with increased morbidity and mortality in patients with chronic kidney disease. The aim of this study was to assess whether a meal with high phosphorus content would affect plasma phosphate in the hours th
Autor:
Ayub Akbari, Salmaan Kanji, Owen Clarkin, Edward G. Clark, Jennifer Kong, Christopher R. McCudden, Brianna Lahey, Wael Shabana, Johnny W. Huang, Swapnil Hiremath, Benjamin J.W. Chow
Publikováno v:
Kidney International Reports
Kidney International Reports, Vol 6, Iss 2, Pp 396-403 (2021)
Kidney International Reports, Vol 6, Iss 2, Pp 396-403 (2021)
Introduction N-acetylcysteine (NAC) is an antioxidant that can regenerate glutathione and is primarily used for acetaminophen overdose. NAC has been tested and used for preventing iatrogenic acute kidney injury or slowing the progression of chronic k
Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort
Autor:
Tiziano Lucchi, Tiziana Sampietro, Giuliano Boscutti, Fabrizio Veglia, Alice Ossoli, Loreto Gesualdo, Marcello Arca, Laura Calabresi, Laura D'Erasmo, Chiara Pavanello
Publikováno v:
Journal of Lipid Research, Vol 61, Iss 12, Pp 1784-1788 (2020)
J Lipid Res
J Lipid Res
Familial LCAT deficiency (FLD) is a rare genetic disorder of HDL metabolism, caused by loss-of-function mutations in the LCAT gene and characterized by a variety of symptoms including corneal opacities and kidney failure. Renal disease represents the
Publikováno v:
Nefrología, Vol 40, Iss 5, Pp 499-505 (2020)
Resumen: El uso de fármacos inhibidores de la proprotein convertase subtilisin/kexin type 9 (iPCSK9) ha supuesto un cambio en el tratamiento de la dislipidemia en sus efectos sobre los eventos cardiovasculares. Actualmente, disponemos de 2 principio
Autor:
Valentine Gillion, Nathalie Demoulin, Benoit Buysschaert, Michel Jadoul, Johann Morelle, Selda Aydin
Publikováno v:
Kidney International Reports
Kidney International Reports, Vol 5, Iss 9, Pp 1503-1509 (2020)
Kidney international reports, Vol. 5, no. 9, p. 1503-1509 (2020)
Kidney International Reports, Vol 5, Iss 9, Pp 1503-1509 (2020)
Kidney international reports, Vol. 5, no. 9, p. 1503-1509 (2020)
Background Oxalate nephropathy is a potentially underestimated cause of kidney failure characterized by massive deposition of calcium oxalate crystals in the renal parenchyma. The prevalence and modes of presentation of this entity are ill-defined. M
Autor:
Mannix Imani Masimango, Pierre Wallemacq, Catherine Fillée, Michel P. Hermans, Espoir Bwenge Malembaka, Sophie Limou, Cheryl A. Winkler, William D'Hoore, Ernest Kiswaya Sumaili, Michel Jadoul
Publikováno v:
Kidney International Reports
Kidney international reports, Vol. 5, no. 8, p. 1251-1260 (2020)
Kidney International Reports, p. 10p. (2020)
Kidney international reports, Vol. 5, no. 8, p. 1251-1260 (2020)
Kidney International Reports, p. 10p. (2020)
Background The prevalence of chronic kidney disease (CKD) in African American individuals is high but whether this applies to native populations in sub-Saharan Africa is unclear. Methods In a cross-sectional study, we assessed the prevalence and risk